Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 10, 2012, Pages 2673-2678

  Yang, Y ^a   Deng, L ^a   Li, X ^a   Shi, Z ^a,b   Chen, D ^c   Chen, X ^a   Li, M ^a   Ma, L ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; FEMALE; FULMINANT VIRAL HEPATITIS IN LATE PREGNANCY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MODEL FOR END STAGE LIVER DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; VIRUS HEPATITIS;

ADULT; CESAREAN SECTION; CONFIDENCE INTERVALS; END STAGE LIVER DISEASE; FEMALE; GESTATIONAL AGE; HEPATITIS; HEPATITIS VIRUSES; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TERTIARY CARE CENTERS; TIME FACTORS; YOUNG ADULT;

EID: 84869120203     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1613-y     Document Type: Article

References (31)

1. Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97-106
2. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI (1981) Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252-255
3. Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS (2005) Clinical characteristics of fulminant hepatitis in pregnancy. World J Gastroenterol 11:4600-4603
4. Shi Z, Li X, Yang Y, Ma L, Schreiber A (2012) Obstetrical management of fulminant viral hepatitis in late pregnancy. Reproductive Sys Sexual Disord 1:102. doi:10.4172/2161-038X.1000102
5. Jashnani KD, Rupani AB, Wani RJ (2009) Maternal mortality: an autopsy audit. J Postgrad Med 55:12-16
6. Ujah IA, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE (2005) Factors contributing to maternal mortality in northcentral Nigeria: a seventeen-Year review. Afr J Reprod Health 9:27-40
7. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470
8. Kamath PS, Kim WR, Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797-805
9. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, Meregaglia D, Nicolini A, Lubatti L, Riggio O (2002) MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 36:494-500
10. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91-96
11. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52:134-139
12. Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS (2005) Prognostic factors of fulminant hepatitis in pregnancy. Chin Med J (Engl) 118:1754-1757
13. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA (2010) Liver disease in pregnancy. Lancet 375:594-605
14. Liu H, Hu J, Cai Q, Liu T (2000) Research progress of effective anti-hepatitis B virus components of Chinese medicine. Pharm J Chin PLA 16:265-267
15. Model for End-Stage Liver Disease (MELD). Mayo Clinic. http://www.mayoclinic.org/meld. Accessed 10 June 2011
16. Hay JE (2008) Liver disease in pregnancy. Hepatology 47:1067-1076
17. Yu JW, Wang GQ, Zhao YH, Sun LJ, Wang SQ, Li SC (2007) The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment. Hepatobiliary Pancreat Dis Int 6:492-496
18. Qian ZP, Liao YB, Wang JF, Wu SM (2006) The evaluating function of MELD scoring system on prognosis of patients with chronic severe hepatitis B. Gan Zang 11:316-317
19. Zhou J, He WF, Tang XE (2007) Analysis of short-Term prognosis on patients with chronic severe hepatitis B using the Model for End-stage Liver Disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19:416-418
20. Chen RL, Luo RH, Chong YT, Wu YK, Zhao ZX, Gao ZL (2006) The value of MELD scoring system on short-Term prognosis of patients with chronic severe hepatitis B. Zhongshan Da Xue Xue Bao (Yi Xue Ke Xue Ban) 27:594-595
21. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11:336-343
22. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, KremersW,Wiesner R, Kamath P, Klintmalm G (2006) Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130:1652-1660
23. Wong ZH, Cai SQ (2005) Analysis of prognosis on patients with severe viral hepatitis using the Model for End-stage Liver Disease. Zhonghua Gan Zang Bing Za Zhi 13:249-251
24. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER (2004) Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 4:1798-1804
25. Zhao YQ, Hu XB, Li YP, Zhou Y (2004) Analysis of MELD scoring system on chronic severe hepatitis. Xiandai Linchuang Yixue Shengwu Gongchengxue Zazhi 10:396-397
26. Reuben A (2002) Child comes of age. Hepatology 35:244-245
27. Naiki T, Nakayama N, Mochida S, Oketani M, Takikawa Y, Suzuki K, Tada SI, Ichida T, Moriwaki H, Tsubouchi H, the Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labor and Welfare of Japan (2012) Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: application to indication criteria for liver transplantation. Hepatol Res 42:68-75
28. Bie CQ, Yang DH, Tang SH, Huang W (2009) The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res 39:779-785
29. Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-Analysis. Obstet Gynecol 116:147-159
30. Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-To-child transmission-A meta-Analysis. Int J Infect Dis 14:e622-e634
31. Yang Y, Deng L, Li X, Shi Z, Jiang P, Chen D, Yu Y,Wang Z, Tang X, Zhao S, Feng L, Tan H, Ma L (2011) Analysis of prognosisassociated factors in fulminant viral hepatitis during pregnancy in China. Int J Gynaecol Obstet 114:242-245